CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 71 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-19 | Young Caroline Director | Purchase | +19 | $2.69 | $51 | 15,834 |
| 2022-04-19 | Jones James Director | Purchase | +28 | $2.69 | $75 | 20,449 |
| 2022-04-19 | Galante Joseph C Director | Purchase | +56 | $2.69 | $151 | 45,229 |
| 2022-04-19 | Krogulski Kenneth Director | Purchase | +94 | $2.69 | $253 | 184,423 |
| 2022-04-18 | Young Caroline Director | Purchase | +19 | $2.63 | $50 | 15,815 |
| 2022-04-18 | Jones James Director | Purchase | +28 | $2.63 | $74 | 20,421 |
| 2022-04-18 | Galante Joseph C Director | Purchase | +56 | $2.63 | $147 | 45,173 |
| 2022-04-18 | Krogulski Kenneth Director | Purchase | +94 | $2.63 | $247 | 184,329 |
| 2022-04-16 | Krogulski Kenneth Director | Purchase | +94 | $2.71 | $255 | 184,235 |
| 2022-04-14 | Young Caroline Director | Purchase | +19 | $2.71 | $51 | 15,796 |
| 2022-04-14 | Jones James Director | Purchase | +28 | $2.71 | $76 | 20,393 |
| 2022-04-14 | Galante Joseph C Director | Purchase | +56 | $2.71 | $152 | 45,117 |
| 2022-03-20 | Herman James L VP and Chief Compliance Office | Shares withheld for taxes | −1,280 | $2.74 | $4K | 40,721 |
| 2022-03-20 | KAZIMI A J Chairman and CEO | Shares withheld for taxes | −37,205 | $2.74 | $102K | 5,753,358 |
| 2022-03-17 | Cearnal Martin E Sr VP/Chief Commercial Officer | Other disposition | −15,000 | $2.74 | $41K | 163,473 |
| 2022-03-17 | Cearnal Martin E Sr VP/Chief Commercial Officer | Other disposition · Options (right to buy) | −5,000 | 0 | ||
| 2022-03-16 | Pavliv Leo SVP and Chief Development Off. | Returned to the company · Options (right to buy) | −5,000 | 0 | ||
| 2022-03-16 | Young Caroline Director | Grant or award | +1,000 | $2.59 | $3K | 15,777 |
| 2022-03-16 | Pavliv Leo SVP and Chief Development Off. | Grant or award · Options (right to buy) | +5,000 | 5,000 | ||
| 2022-03-16 | Krogulski Kenneth Director | Grant or award | +1,000 | $2.59 | $3K | 184,141 |
Page 125 of 207 · 4,129 trades